Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

This Common Dog Food Ingredient Has Been Linked to Heart Failure — Is Your Pup at Risk?

As dog owners, we try to do what’s best for our pets. We spend time and money selecting food that we believe is high-quality. Many of us switched to “grain-free” diets, believing they were more natural or healthier. Then, in 2018, the U.S. Food and Drug Administration (FDA) announced it…

Budget and the Bees · Oct 29, 2025

2 Stocks to Buy Under $10 That Wall Street Loves

While penny stocks are risky, they also have the potential to deliver outsized gains.

Barchart · Oct 29, 2025

Popular Thai herbal inhalers recalled after contamination warning

Hong Thai Herbal recalls batch and apologises after Thailand’s food and drug watchdog reveals microbial contamination

The Independent UK · Oct 29, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Hong Thai Herbal Inhaler Fails Safety Tests — Is Your Favourite Brand Contaminated?

Thailand's FDA recalls Hong Thai Herbal Mixed Balm Formula 2 after microbial contamination found in routine tests, prompting regional consumer safety warnings.

International Business Times UK · Oct 29, 2025

Over 127,000 pounds of popular BBQ pulled pork sandwiches recalled over choking hazard

There have currently been no reported illnesses as a result of the choking hazard, the FDA reports

The Independent UK · Oct 28, 2025

Philips Ultrasound Devices Deemed Adulterated Over Manufacturing And Oversight Lapses

The U.S. Food and Drug Administration (FDA) found that devices made at Koninklijke Philips N.V.'s (NYSE:PHG) Bothell, Reedsville, and Nederland facilities were adulterated due to manufacturing, storage, and quality control practices that failed to meet current Good Manufacturing Practice (GMP) standards.

Benzinga · Oct 28, 2025

DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor

DexCom Inc (NASDAQ:DXCM) is facing renewed scrutiny after three people with diabetes reportedly died following issues with its G7 continuous glucose monitor, according to adverse event filings submitted to the Food and Drug Administration in September.

Benzinga · Oct 28, 2025

Read news from The Economist, FT, and more,
with one subscription

7 Medications Pulled for Links to Devastating Outcomes

We like to believe the pills prescribed to us are perfectly safe—that each one has passed through rigorous testing, expert oversight, and endless studies. And for the most part, that’s true. But every now and then, history reminds us that even modern medicine can stumble spectacularly. Some drugs once hailed…

Everybody Loves Your Money · Oct 28, 2025

Regeneron's Q3 Earnings Outperform Expectations With Dupixent Strength Balancing Eylea Weakness

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) on Tuesday reported third-quarter adjusted earnings of $11.83 per share, down 5% year-over-year, beating the consensus of $9.59.

Benzinga · Oct 28, 2025

5 Under-the-Radar Biotech Stocks That Could Soar in 2026

These smaller innovators are quietly advancing promising therapies that could unlock their true potential.

Barchart · Oct 28, 2025

A New Hair Loss Medication, VDPHL01, Could Soon Hit the Market

Here's what the pros have to say about VDPHL01.

Marie Claire · Oct 28, 2025

8 Pharmacy Shelves That Stock Identical Generics Cheaper

Grocery Coupon Guide · Oct 27, 2025

‘A medical miracle’: is period blood ‘the most overlooked opportunity’ in women’s health?

Period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions – including difficult-to-diagnose endometriosis

The Guardian - US · Oct 27, 2025

Australia must ‘step up to prevent catastrophic and preventable loss of life’ amid Trump cuts, former CDC boss says

Dr Tom Frieden served as director of the US health body under Barack Obama until 2017 and warns about cuts under Donald Trump

The Guardian - AU · Oct 25, 2025

Get all your
news in one place.

100's of premium titles.
One news app.

International Business Times UK · Oct 25, 2025

Atorvastatin Recall 2025 Explained: What the Drug Is, Which Products Are Impacted and What Patients Should Do

The FDA recalls over 140,000 bottles of Atorvastatin after failed quality tests. Find out which products are affected and what patients should do next.

The Independent UK · Oct 24, 2025

FDA approves new pill for menopausal women to treat hot flashes and night sweats

Lynkuet was approved by the FDA Friday to treat moderate-to-severe hot flashes and night sweats

The Independent UK · Oct 24, 2025

Check your cabinets: More than 140,000 bottles of cholesterol medication part of elevated recall over health risk

The tablets were distributed nationwide in up to 1,000-count bottles

Benzinga · Oct 24, 2025

Biogen's Immunology Pipeline Has Long-Term Potential: Analyst

On Friday, Biogen Inc. (NASDAQ:BIIB) and Vanqua Bio announced a license agreement granting Biogen exclusive worldwide rights to Vanqua's preclinical, oral C5aR1 antagonist. The agreement strengthens Biogen's immunology.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Oct 24, 2025

Dupixent Pushes Sanofi's Quarterly Sales Past $14.5 Billion Mark

Sanofi SA (NASDAQ:SNY) reported third-quarter sales of $14.55 billion (12.43 billion euros), beating the consensus of $14.46 billion. Sales increased 2.3% year over year, up 7% in constant currency.

Benzinga · Oct 24, 2025

FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep

On Friday, the U.S. Food and Drug Administration (FDA) approved GSK Plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone (BVd) for adult patients with relapsed or refractory multiple myeloma who have received at least two prior lines of therapy.

Everybody Loves Your Money · Oct 24, 2025

7 FDA Approvals That Should Never Have Happened

Every time you see the words “FDA approved,” it’s supposed to mean safety, science, and trust. After all, the Food and Drug Administration is the final checkpoint before a product reaches your medicine cabinet, right? But history says otherwise. Over the years, some truly shocking—and sometimes disastrous—products have slipped through…

International Business Times · Oct 24, 2025

Neutrogena Issues Recall of Makeup Wipes That Tested Positive for Harmful Bacteria

Neutrogena recalls makeup wipes after tests found harmful bacteria, urging consumers to stop use immediately.

Benzinga · Oct 24, 2025

Intel, Scienture Holdings, Ford, Deckers, And Super Micro Computer: Why These 5 Stocks Are On Investors' Radars Today

Major U.S. indices closed higher on Thursday, with the Dow Jones Industrial Average up 0.3% at 46,734.61, the SP 500 advancing nearly 0.6% to 6,738.44, and the Nasdaq climbing about 0.9% to 22,941.79.These are the top stocks that gained the attention of retail traders and investors through the day: Intel…

Grocery Coupon Guide · Oct 23, 2025

9 OTC Cold Remedies That Don’t Work as Advertised

When you have a cold, you will do almost anything to feel better fast. The pharmacy aisle is filled with over-the-counter (OTC) remedies that promise quick relief from your symptoms. However, many of these popular products make claims that are not supported by strong scientific evidence. While they may offer…

The Independent UK · Oct 23, 2025

Three Coke products all under recall for ‘foreign material’ inside the cans

Coca-Cola and the FDA say they have not received any reports of consumers being injured by the recalled Coke and Sprite cans

1 … 92 93 94 95

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.